Table 1 Summary of clinical data of the patients studied
Number (n) | ||
|---|---|---|
Patients completing the study | Male | 19 |
Female | 19 | |
Age (years) | Total cohort [median (minimum - maximum) | 79.0 (66–93) |
FEV1/ FVC < 70% on day 1 (n = 18) | Male | 10 |
Female | 8 | |
Mini Mental Status Test performed (n = 22) | Cognitive decline | 16 |
Normal cognition | 6 | |
Classification GOLD | I | 9 |
II | 17 | |
III | 12 | |
IV | 0 | |
Classification COPD | A | 3 |
B | 23 | |
C | 0 | |
D | 12 | |
Type of inhaler device | MDI | 3 |
DPI | 26 | |
SMI (Respimat™) | 9 | |
Drop outs | – | 3 |